(Q45152445)

10 December 2017

title

Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats (English)

1 reference

10 December 2017

Kim JC

1

1 reference

10 December 2017

Shin DH

2

1 reference

10 December 2017

Kim SH

3

1 reference

10 December 2017

Kim JK

4

1 reference

10 December 2017

Park SC

5

1 reference

10 December 2017

Son WC

6

1 reference

10 December 2017

Lee HS

7

1 reference

10 December 2017

Suh JE

8

1 reference

10 December 2017

Kim CY

9

1 reference

10 December 2017

Ha CS

10

1 reference

10 December 2017

Chung MK

11

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Regulatory Toxicology and Pharmacology

10 December 2017

published in

1 reference

10 December 2017

volume

40

1 reference

10 December 2017

issue

3

1 reference

10 December 2017

page(s)

356-369

1 reference

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Properties of Sufficiency and Statistical Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Irinotecan-induced immune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Toxicity patterns of cytotoxic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

New Tables for Multiple Comparisons with a Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Subchronic toxicity of plant sterol esters administered by gavage to Sprague-Dawley rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Effects of prenatal exposure to the environmental pollutant 2-bromopropane on embryo-fetal development in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

26-Week repeated oral dose toxicity study of the new quinolone antibacterial DW-116 in Sprague-Dawley rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Preformulation studies of a novel camptothecin anticancer agent, CKD-602: physicochemical characterization and hydrolytic equilibrium kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Preclinical and phase I clinical studies with Ckd-602, a novel camptothecin derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Mastocytosis and fibrosis: role of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

In vitro pharmacodynamics of CKD-602 in HT-29 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Topoisomerase I inhibitors: review and update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

The current status of camptothecin analogues as antitumor agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Subchronic and chronic toxicity of ingested 1,3-dichloropropene in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Clinical applications of the camptothecins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

Reference range data base for serum chemistry and hematology values in laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.09.002

10.1016/J.YRTPH.2004.09.002

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference